BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 8898543)

  • 1. Perturbing gene expression with oligodeoxynucleotides: research and potential therapeutic applications.
    Gewirtz AM
    Mt Sinai J Med; 1996; 63(5-6):372-80. PubMed ID: 8898543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antisense oligonucleotides as therapeutics for malignant diseases.
    Ho PT; Parkinson DR
    Semin Oncol; 1997 Apr; 24(2):187-202. PubMed ID: 9129689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Applications of antisense oligonucleotides in oncology.
    Pierga JY; Magdelenat H
    Cell Mol Biol (Noisy-le-grand); 1994 May; 40(3):237-61. PubMed ID: 7920172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antisense therapy for cancer.
    Gleave ME; Monia BP
    Nat Rev Cancer; 2005 Jun; 5(6):468-79. PubMed ID: 15905854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oligonucleotide therapeutics: clothing the emperor.
    Gewirtz AM
    Curr Opin Mol Ther; 1999 Jun; 1(3):297-306. PubMed ID: 11713794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of protooncogene expression by antisense oligodeoxynucleotides: biological and therapeutic implications.
    Calabretta B
    Cancer Res; 1991 Sep; 51(17):4505-10. PubMed ID: 1873794
    [No Abstract]   [Full Text] [Related]  

  • 7. Antisense strategy in hematological malignancies.
    Warzocha K
    Cytokines Cell Mol Ther; 1999 Mar; 5(1):15-23. PubMed ID: 10390076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The therapeutic potential of antisense oligonucleotides.
    Sharma HW; Narayanan R
    Bioessays; 1995 Dec; 17(12):1055-63. PubMed ID: 8634067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Not nonsense but antisense--applications of antisense oligonucleotides in different fields of medicine.
    Oberbauer R
    Wien Klin Wochenschr; 1997 Jan; 109(2):40-6. PubMed ID: 9123943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted delivery of oncogene-selective antisense oligonucleotides in neuroectodermal tumors: therapeutic implications.
    Pastorino F; Brignole C; Marimpietri D; Di Paolo D; Zancolli M; Pagnan G; Ponzoni M
    Ann N Y Acad Sci; 2004 Dec; 1028():90-103. PubMed ID: 15650235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myb targeted therapeutics for the treatment of human malignancies.
    Gewirtz AM
    Oncogene; 1999 May; 18(19):3056-62. PubMed ID: 10378701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular therapy to inhibit NFkappaB activation by transcription factor decoy oligonucleotides.
    Morishita R; Tomita N; Kaneda Y; Ogihara T
    Curr Opin Pharmacol; 2004 Apr; 4(2):139-46. PubMed ID: 15063357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antisense strategies in the treatment of leukemias.
    Calabretta B; Skorski T; Ratajczak MZ; Gewirtz AM
    Semin Oncol; 1996 Feb; 23(1):78-87. PubMed ID: 8607034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A potential role for antisense oligonucleotide analogues in the development of oncogene targeted cancer chemotherapy.
    Tidd DM
    Anticancer Res; 1990; 10(5A):1169-82. PubMed ID: 2241097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The gene expression profile of extraskeletal myxoid chondrosarcoma.
    Subramanian S; West RB; Marinelli RJ; Nielsen TO; Rubin BP; Goldblum JR; Patel RM; Zhu S; Montgomery K; Ng TL; Corless CL; Heinrich MC; van de Rijn M
    J Pathol; 2005 Aug; 206(4):433-44. PubMed ID: 15920699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in the development of ribozymes and antisense oligodeoxynucleotides as antiviral agents for human papillomaviruses.
    Alvarez-Salas LM; Benítez-Hess ML; DiPaolo JA
    Antivir Ther; 2003 Aug; 8(4):265-78. PubMed ID: 14518695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer Drug Development: New Targets for Cancer Treatment.
    Curt GA
    Oncologist; 1996; 1(3):II-III. PubMed ID: 10387987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antisense oligonucleotides.
    Calabretta B; Skorski T; Zon G
    Semin Cancer Biol; 1992 Dec; 3(6):391-8. PubMed ID: 1286160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.